COVID-19 is fast-tracking the industry’s slow move from fewer in-person Pharma HCP dealings visits to digital and virtual approaches. COVID-19 has driven vast changes in what healthcare providers need and value from pharma companies, and as a result, the industry is striving to develop new ways to engage with physicians. Experts say this is just […]
